Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis

References

• Miziołek B, Bergler-Czop B, Stańkowska A, Brzezińska-Wcisło L. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review. Cutan Ocul Toxicol 2017;36:77–84.
   PubMed Web of Science ®Google Scholar
• Onder HI, Turan H, Kilic AC, et al. Premacular hemorrhage due to isotretinoin use. Cutan Ocul Toxicol 2013;32:170–172.
   PubMed Web of Science ®Google Scholar
• Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, et al. Isotretinoin and the eye: a review for the dermatologist. Dermatol Ther 2020;33:e14029.
   PubMed Web of Science ®Google Scholar
• Ozyol P, Ozyol E, Yildirim FE. Remodeling of cornea with isotretinoin treatment. Eye Contact Lens 2021;47:366–371.
   PubMed Web of Science ®Google Scholar
• Karalezli A, Borazan M, Altinors DD, Dursun R, et al. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea 2009;28:46–50.
   PubMed Web of Science ®Google Scholar
• Polat M. Kükner Ş. The effect of oral isotretinoin on visual contrast sensitivity and amount of lacrimation in patients with acne vulgaris. Cutan Ocul Toxicol 2017;36:35–38.
   PubMed Web of Science ®Google Scholar
• Düzgün E, Özkur E. The effect of oral isotretinoin therapy on meibomian gland morphology and dry eye tests [published online ahead of print, 2020 Jun 8. J Dermatolog Treat 2020;2020:1–7.
   Google Scholar
• Caglar C, Senel E, Sabancilar E, Durmus M. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Int Ophthalmol 2017;37:197–202.
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Irkeç MT, Atakan N, et al. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002;12:173–176.
   PubMed Web of Science ®Google Scholar
• Yildirim Y, Olcucu O, Agca A, et al. Evaluation of corneal topography and biomechanical parameters after use of systemic isotretinoin in acne vulgaris. J Ophthalmol 2014;2014:701361.
   PubMed Web of Science ®Google Scholar
• Elhamaky TR. Efficacy of omega-3 fatty acids and punctal plugs in the prevention of isotretinoin-associated ocular surface disease. Eur J Ophthalmol 2020;2020:1120672120945655.
   Google Scholar
• Oner A, Ferahbas A, Karakucuk S, et al. Ocular side effects associated with systemic isotretinoin. J Toxicol 2005; 23:189–195.
   Web of Science ®Google Scholar
• Cumurcu T, Sezer E, Kilic R, Bulut Y. Comparison of dose-related ocular side effects during systemic isotretinoin administration. Eur J Ophthalmol 2009;19:196–200.
   PubMed Web of Science ®Google Scholar
• Tanriverdi C, Nurozler Tabakci B, Donmez S. Longitudinal assessment of meibomian glands and tear film layer in systemic isotretinoin treatment. Eur J Ophthalmol 2021;2020:11206721211018361.
   Google Scholar
• Yuksel N, Ozer MD, Akcay E, et al. Reduced central corneal thickness in patients with isotretinoin treatment. Cutan Ocul Toxicol 2015;34:318–321.
   PubMed Web of Science ®Google Scholar
• Ucak H, Aykut V, Ozturk S, et al. Effect of oral isotretinoin treatment on retinal nerve fiber layer thickness. J Cutan Med Surg 2014;18:236–242.
   PubMed Web of Science ®Google Scholar
• Bakbak B, Gedik S, Koktekir BE, et al. Structural and functional assessment in patients treated with systemic isotretinoin using optical coherence tomography and frequency-doubling technology perimetry. Neuroophthalmology 2013;37:100–103.
   PubMed Web of Science ®Google Scholar
• Yılmaz U, Küçük E, Koç Ç, Özköse A. Investigation of the effects of systemic isotretinoin treatment on retinal nerve fiber layer and macula. J Dermatolog Treat 2017;28:314–317.
   PubMed Web of Science ®Google Scholar
• Sekeryapan B, Dılek N, Oner V, et al. Retinal nerve fiber layer and ganglion cell layer thickness in patients receiving systemic isotretinoin therapy. Int Ophthalmol 2013;33:481–484.
   PubMed Web of Science ®Google Scholar
• Kapti BH, Aslan G, Yavruoğlu MA. Evaluation of retinal nerve fiber layer changes with oral isotretinoin treatment. Ophthalmol Ther 2013;2:19–23.
   PubMedGoogle Scholar
• Karadag O, Kocamaz M, Dastan M, Ozturk Durur S. Assessment of macular choroidal thickness, central macular thickness and retinal nerve fiber layer in patients receiving oral isotretinoin treatment. Cutan Ocul Toxicol 2020;39:233–236.
   PubMed Web of Science ®Google Scholar
• Demirok G, Topalak Y, Gündüz Ö, et al. The long-term effect of oral isotretinoin therapy on macula ganglion cell complex thickness. Cutan Ocul Toxicol 2017;36:259–262.
   PubMed Web of Science ®Google Scholar
• Yasar E, Gurlevik U, Kemeriz F, Atalay E. Effect of isotretinoin on myopia and axial length: a pilot study. Cutan Ocul Toxicol 2020;39:385–388.
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Sener S, Ozsoy E, Doganay S. Changes in anterior chamber parameters with the Pentacam rotating Scheimpflug and axial length measurements by ultrasound in patients who use isotretinoin. Curr Eye Res 2012;37:395–398.
   PubMed Web of Science ®Google Scholar
• Yavuz C, Ozcimen M. An evaluation of peripapillar choroidal thickness in patients receiving systemic isotretinoin treatment. Cutan Ocul Toxicol 2019;38:25–28.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336–341.
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute, Study Quality Assessment Tools, (2021), https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
   Google Scholar
• Al Saad M, Shehadeh A, Meqbil J, et al. Relationship between central corneal thickness and ganglionic-inner plexiform cell layer and retinal nerve fibre layer thickness in normal subjects. Clin Ophthalmol 2021;15:1809–1812.
   PubMed Web of Science ®Google Scholar
• Feng Y, Feng G, Peng S, Li H. The effect of hormone replacement therapy on dry eye syndrome evaluated with schirmer test and break-up time. J Ophthalmol 2015;2015:420302.
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011;52:2006–2049.
   PubMed Web of Science ®Google Scholar
• Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland morphology and tear osmolarity: changes with accutane therapy. Cornea 1991;10:286–290.
   PubMed Web of Science ®Google Scholar
• Moy A, McNamara NA, Lin MC. Effects of isotretinoin on meibomian glands. Optom Vis Sci 2015;92:925–930.
   PubMed Web of Science ®Google Scholar